Lack of essential information in spontaneous reports of adverse drug reactions in Catalonia—a restraint to the potentiality for signal detection
- 1 March 2017
- journal article
- pharmacoepidemiology and-prescription
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 73 (6) , 751-758
Abstract
The aim of this study is to analyze the quality of the information contained in the adverse drug reactions (ADR) reports and to describe the magnitude and characteristics of the lacking information.Keywords
This publication has 13 references indexed in Scilit:
- Why are there deadly drugs?BMC Medicine, 2015
- Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysisBMC Medicine, 2015
- Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic areaEuropean Journal of Clinical Pharmacology, 2014
- vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality IssuesDrug Safety, 2013
- Quality of Adverse Drug Reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilanceJournal of Public Health, 2013
- Pharmacovigilance: methods, recent developments and future perspectivesEuropean Journal of Clinical Pharmacology, 2008
- Drug-Review Deadlines and Safety ProblemsNew England Journal of Medicine, 2008
- Knowledge creation about ADRs – turning the perspective from the rear mirror to the projector?British Journal of Clinical Pharmacology, 2007
- Calidad de la publicación de reacciones adversas a medicamentos en la sección de Cartas al Director de cuatro revistas españolas de medicina interna y medicina generalAtencion Primaria, 2006
- Adverse Drug Event Surveillance and Drug Withdrawals in the United States, 1969-2002Archives of internal medicine (1960), 2005